Global Biomarker Research Services Market: Forecast, Trends, and Opportunities
Biomarker Research Services Market
The global biomarker research
services market is expected to experience significant growth in the coming
years, with an increasing demand for personalized medicine and precision
medicine driving the market. Biomarkers are measurable indicators of a biological
state or condition and are used in the diagnosis, prognosis, and treatment of
diseases. Biomarker research services provide a range of services, including
biomarker identification, development, validation, and analysis, to support
drug development and clinical trials.
The global
biomarker research services market was valued at USD 10.1 billion in
2020 and is expected to grow at a compound annual growth rate (CAGR) of 14.5%
from 2021 to 2028. The increasing prevalence of chronic diseases, rising
healthcare expenditure, and advancements in technology are some of the key factors
driving the market growth.
The oncology segment is expected
to dominate the biomarker research services market during the forecast period.
This can be attributed to the increasing incidence of cancer worldwide and the
growing demand for targeted therapies. Biomarkers play a crucial role in the
diagnosis, prognosis, and treatment of cancer, and the development of companion
diagnostics is driving the growth of the oncology segment.
Another key trend in the biomarker
research services market is the growing demand for non-invasive and
minimally invasive diagnostic techniques. Biomarkers can be detected in bodily
fluids such as blood, urine, and saliva, and the use of these fluids for diagnostic
purposes is gaining popularity. Non-invasive and minimally invasive diagnostic
techniques reduce patient discomfort and improve patient compliance, thereby
driving the demand for biomarker research services.
The Asia Pacific region is
expected to witness significant growth in the biomarker research services
market during the forecast period. This can be attributed to the increasing
prevalence of chronic diseases in the region, rising healthcare expenditure,
and growing investments in healthcare infrastructure. In addition, the presence
of a large patient pool and favorable government initiatives are driving the
growth of the biomarker research services market in the region.
The key players operating in the
global biomarker research services market include Bio-Rad Laboratories, Inc.,
Qiagen N.V., Creative Biolabs, Proteome Sciences plc, Charles River
Laboratories International, Inc., Eurofins Scientific, GenScript Biotech
Corporation, Merck KGaA, and Thermo Fisher Scientific Inc. These players are focusing
on strategic collaborations, partnerships, and acquisitions to expand their
market presence and strengthen their product portfolios.
In conclusion, the global
biomarker research services market is poised for significant growth in the
coming years, driven by the increasing demand for personalized and precision
medicine, advancements in technology, and growing healthcare expenditure. The
oncology segment is expected to dominate the market, and the Asia Pacific
region is expected to witness significant growth. The key players in the market
are focusing on strategic collaborations and partnerships to expand their
market presence and strengthen their product portfolios.
Comments
Post a Comment